Bayer is pressing ... given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was no significant observed increase in bleeding with asundexian at any dose or compared ...

As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...

The mechanism of action of aspirin as an inhibitor of prostanoid biosynthesis was described approximately 50 years ago. The description of human pharmacology of low-dose aspirin largely relied on ...

Results from the first patient cohort (N=5) of an open-label proof of concept academic study with low-dose IL-2 and CTLA4-Ig demonstrated a rapid and durable statistically significant increase in ...

For the overall group, including those who may have missed doses, the reduction was 18.7% with the high dose, 15.6% with the low dose, and 3.9% with placebo. The increase in weight loss with the ...

A systematic review and meta-analysis indicates that adding a low dose of a widely available antimalaria drug to artemisinin-based combination therapy (ACT) is as safe and effective at blocking ...

A high TSH also may be found in people being treated for either low or high thyroid function: With hypothyroidism, a high TSH usually means that the dose of thyroid hormone replacement needs to be ...

Tradition and habit may have considerable influence over dose selection. A review of the role and dosage of heparin during PCI appears to be overdue ...

Analyses of bleeding outcomes were based on the on-treatment population including all randomised patients enrolled in the substudy who received at least one dose of the study drug and included all ...